Trevi Therapeutics, Inc. (NasdaqGM:TRVI) currently has a current ratio of 3.30. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations and in turn a more healthy balance sheet.
Beginner traders have the tendency to make many mistakes when starting out. Although this comes with the territory, continually making the same mistakes will most likely put the trader on the sidelines very quickly. Learning from previous mistakes is what helps transform a mediocre trader into a good one. Successful traders are highly adept at creating detailed plans, managing risk, and reviewing previous trading records. Scooping up profits from the stock market is no easy task. Even with the best intentions and preparation, things may not work out as planned. Taking a look at the market from various angles may help the trader see the bigger picture. Market environments are constantly changing, and traders need to be ready for these changes and adapt accordingly in order to be successful over the long-term.
Yield
The Q.i. Value of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 72.00000. The Q.i. Value is a helpful tool in determining if a company is undervalued or not. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The lower the Q.i. value, the more undervalued the company is thought to be. The Value Composite One (VC1) is a method that investors use to determine a company’s value. The VC1 of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 88. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 85.
Volatility & Price
Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The Volatility 12m of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 0.000000. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The lower the number, a company is thought to have low volatility. The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months. The Volatility 3m of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 0.000000. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 0.000000.
We can now take a quick look at some historical stock price index data. Trevi Therapeutics, Inc. (NasdaqGM:TRVI) presently has a 10 month price index of 1.12801. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.12801, the 24 month is 1.12801, and the 36 month is 1.12801. Narrowing in a bit closer, the 5 month price index is 1.12801, the 3 month is 1.12801, and the 1 month is currently 1.12801.
Key Metrics
The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 5. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.
The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 18883. The lower the ERP5 rank, the more undervalued a company is thought to be. The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. The MF Rank of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 16375. A company with a low rank is considered a good company to invest in. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.
The Leverage Ratio of Trevi Therapeutics, Inc. (NasdaqGM:TRVI) is 0.066923. Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two. Companies take on debt to finance their day to day operations. The leverage ratio can measure how much of a company’s capital comes from debt. With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.
C-Score
Trevi Therapeutics, Inc. (NasdaqGM:TRVI) currently has a Montier C-score of -1.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.
Managing the stock portfolio can be a very challenging task. To manage the portfolio successfully, it can take a lot of dedicated time, effort, and perseverance. Studying the market and being in tune with the economic landscape can help investors gain the knowledge that is needed to come out on top. Controlling emotions and consistently following a plan may be the keys to keep the investor on track. As many seasoned investors know, the stock market can be a wild ride full of many ups and downs. Being able to stay calm and focused during the rocky periods can assist the investor when making those highly important portfolio decisions.
Just-released report names Cannabis Stock of the Year for 2019! Their last pick has seen a +1,200% return since he released it! This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that is unlike anything else on the market… You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more. Click here to receive your Free Report immediately! |
The Current Ratio of Kværner ASA (OB:KVAER) is 1.84. The Current Ratio is used by investors to determine whether a company can pay short term and long term debts. The current ratio looks at all the liquid and non-liquid assets compared to the company’s total current liabilities. A high current ratio indicates that the company does not have trouble managing their working capital. A low current ratio (when the current liabilities are higher than the current assets) indicates that the company may have trouble paying their short term obligations. It is wise to compare a company’s current ratio to that of other companies in the same industry. It would also be wise to look at the trend of the current ratio for a given company over a given time period.
There are many factors that can affect the health of a company. This is one reason why stock trading can be extremely difficult at times. Because there are always so many things to take into consideration, it may be next to impossible to create a formula that will continually beat the market. Even after all the data has been scrutinized and the numbers have been crunched, the investor still has to make sense of the information and figure out what to do with it. Knowing how to use the information about publically traded companies can end up being the difference between handsome gains and devastating losses.
F Score, ERP5 and Magic Formula
The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Kværner ASA (OB:KVAER) is 4. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.
The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Kværner ASA (OB:KVAER) is 4043. The lower the ERP5 rank, the more undervalued a company is thought to be. The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. The MF Rank of Kværner ASA (OB:KVAER) is 7358. A company with a low rank is considered a good company to invest in. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.
Shareholder Yield
The Q.i. Value of Kværner ASA (OB:KVAER) is 23.00000. The Q.i. Value is a helpful tool in determining if a company is undervalued or not. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The lower the Q.i. value, the more undervalued the company is thought to be. The Value Composite One (VC1) is a method that investors use to determine a company’s value. The VC1 of Kværner ASA (OB:KVAER) is 17. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of Kværner ASA (OB:KVAER) is 10.
The Leverage Ratio of Kværner ASA (OB:KVAER) is 0.044560. Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two. Companies take on debt to finance their day to day operations. The leverage ratio can measure how much of a company’s capital comes from debt. With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.
Volatility & Price
We can now take a quick look at some historical stock price index data. Kværner ASA (OB:KVAER) presently has a 10 month price index of 0.97401. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.75185, the 24 month is 1.21191, and the 36 month is 1.86632. Narrowing in a bit closer, the 5 month price index is 1.25573, the 3 month is 1.07879, and the 1 month is currently 1.00838.
Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The Volatility 12m of Kværner ASA (OB:KVAER) is 37.447300. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The lower the number, a company is thought to have low volatility. The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months. The Volatility 3m of Kværner ASA (OB:KVAER) is 43.808600. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 41.459000.
C-Score
Kværner ASA (OB:KVAER) currently has a Montier C-score of 2.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.
Successful stock market traders and investors don’t usually just become that way overnight. There are often many years of experience behind those winning trades. The amount of data available to investors these days is staggering. Investors have to be able to focus on the provided information and decide which data should be followed and prioritized. Many investors will be keeping a watchful eye on the next round of company earnings reports. As companies start to report quarterly numbers, investors may be able to sift through the data and make some projections on how the stock will perform over the next few quarters.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.